Generated July 2026 from current fund data.
Overview
ARKK is ARK Invest's flagship actively managed ETF tracking disruptive innovation themes across biotech, AI, fintech, and robotics. OARK is a covered-call overlay on ARKK itself—it holds the same underlying fund but sells weekly call options against it to generate income, launched in late 2022. The key distinction: ARKK offers pure capital appreciation with minimal distributions; OARK transforms that growth potential into a 40.94% annualized income stream by systematically capping upside.
How they differ
OARK wraps ARKK in a weekly covered-call collar, meaning it captures ARKK's equity exposure but sacrifices unlimited upside to fund a yield that's roughly 55 times higher than ARKK's annual distribution. OARK's 1.19% expense ratio is also 44 basis points steeper than ARKK's 0.75%, reflecting the cost of weekly option management. The most material difference is structural: OARK's beta of 1.64 is substantially lower than ARKK's 2.44, showing that the call overlay dampens volatility—but also limits gains when the innovation theme accelerates. OARK's weekly payout frequency forces more frequent reinvestment decisions, while ARKK distributes once yearly. At $50.1M in AUM, OARK is a fraction of ARKK's $8.24B, a sign of the strategy's niche appeal and shorter track record (inception November 2022 versus October 2014).
Who each is best for
ARKK: Fits investors with a multi-year time horizon who prioritize capital appreciation in disruptive technology and can tolerate above-market volatility without needing current income. High beta makes it suited to allocators comfortable with concentrated, growth-oriented risk.
OARK: Fits income-focused investors who want exposure to innovation themes but view the typical ARKK growth trajectory as secondary to steady weekly cash flow. Works for those seeking to reduce portfolio volatility through structured income while maintaining innovation equity exposure.
Key risks to know
- NAV erosion at extreme distribution yields. OARK's 40.94% annualized payout rate is unsustainable from ARKK's underlying dividend alone and will likely rely on return-of-capital treatment, eroding net asset value over time as the fund pays out more than it earns.
- Capped upside in growth rallies. The covered-call structure systematically sells away gains above the strike price. In years when ARKK rallies sharply (as it did in 2023), OARK holders forfeit those returns, making it underperform despite holding the same underlying security.
- Liquidity and trading spreads. OARK's $50.1M AUM is thin relative to ARKK's market depth. Investors may face wider bid-ask spreads and larger market-impact costs when entering or exiting positions.
- Beta compression and volatility mismatch. ARKK's 2.44 beta reflects high sensitivity to market drawdowns. While OARK's lower 1.64 beta appears to cushion that risk, the covered-call structure doesn't truly hedge downside—it only caps upside, leaving investors exposed to losses without the compensating gains in rallies.
- Concentration within a single active fund. Both holdings funnel exposure entirely through ARKK's active management. If ARK's strategy underperforms or the fund experiences outflows, holders have no diversification shelter—a particular concern for OARK, which compounds that reliance by adding derivative costs on top.
Bottom line
ARKK suits investors betting on innovation and willing to wait for capital appreciation; OARK trades that upside for immediate, predictable income. If you prioritize growth potential and can absorb volatility, ARKK's simpler structure and lower fees align with that goal. If you need regular cash flow and view innovation exposure as secondary to income, OARK's weekly distributions address that trade-off—though the extreme payout rate suggests reinvestment and NAV dynamics warrant careful monitoring. Past performance doesn't predict future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.